Catalyst Wire Dossier Catalyst Wire Dossier

TDF/FTC

emtricitabine/tenofovir disoproxil fumarate · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TDF/FTC, covering 2020-02-05 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP) [Phase 3]

See pricing